FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to novel IAP inhibitors, where compounds have general formula I , where X, Y, A, R1, R2, R3, R4, R4', R5, R5', R6, R6' have the same values as given in invention description.
EFFECT: obtaining novel IAP inhibitors, which can be used as therapeutic agents for treatment of malignant tumours.
16 cl, 78 ex
Title | Year | Author | Number |
---|---|---|---|
SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
JAK KINASE-MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2529019C2 |
IAP INHIBITORS | 2013 |
|
RU2728789C2 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2012 |
|
RU2662827C2 |
19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
IAP INHIBITORS | 2013 |
|
RU2593259C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
METHOD FOR TREATMENT ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2277909C2 |
NOVEL COMPOUNDS | 2016 |
|
RU2734256C2 |
Authors
Dates
2010-10-20—Published
2005-07-05—Filed